Abstract
Introduction: A prolonged labour may lead to maternal, foetal, neonatal and obstetrical complications. Those risks may be prevented by shortening labour duration. Active management of labour has shown to decrease the occurrence of prolonged labour. Administering antispasmodics during labour could lead to faster and more effective dilatation of the cervix. According to Cochrane collaboration and WHO recommendations, antispasmodics should not be used during labour as there is no evidence of their efficiency and safety. Phloroglucinol is a musculotropic antispasmodic whose the injectable formulation does not have any obstetrical indication. Despite a lack of data, it seems that it is nevertheless used during labour.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
